Article Details

AC Immune Opens New Centers in Phase 1b/2 Trial Evaluating - GlobeNewswire

Retrieved on: 2022-10-04 18:37:44

Tags for this article:

Click the tags to see associated articles and topics

AC Immune Opens New Centers in Phase 1b/2 Trial Evaluating - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2022/10/04/2527812/0/en/AC-Immune-Opens-New-Centers-in-Phase-1b-2-Trial-Evaluating-ACI-24-Targeting-Abeta-in-Alzheimer-s-Disease-and-Down-Syndrome.html

Excerpt

Our firm belief in amyloid has driven our investment in developing therapeutics that target Abeta – including ACI-24 and our monoclonal antibody ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up